Indonesian Health Minister Budi Gunadi Sadikin asked PT Amarox to also produce Paxlovid to deal with the next pandemic. This is necessary because Indonesia is entering the next wave in the form of the Omicron variant. The availability of COVID-19 drugs is needed to help deal with the COVID-19 pandemic in Indonesia.
"Several variants of drugs that we definitely need are anti-viral drugs such as Favipiravir and also Molnupiravir. If we can immediately get access to these medicines, it will be very helpful for handling COVID-19," he said after the inauguration of PT Amarox Pharma Global in the Delta Silicon 3 area, Central Cikarang, Bekasi Regency, West Java Province, Indonesia, January 14, 2022.
Indonesia, he continued, is also preparing to produce its own COVID-19 drugs domestically. Based on previous experience, when there was a spike in cases in several countries, Indonesia experienced difficulties in the logistics of sending medicines from abroad to Indonesia.
"This is very important if we can produce domestic drugs and the manufacturing is also built here," said Budi.
Budi appreciates the existence of PT Amarox as a pharmaceutical provider in Indonesia. He said there are two things that really need cooperation with PT Amarox, in the short term, PT Amarox can help overcome the COVID-19 pandemic. In the medium term, PT Amarox can support the independence of domestic drugs.
"It is hoped that all products that are critical to our nation are produced domestically and we will ensure that there are many drug and medical device companies in Indonesia so that if there is a further pandemic we will not depend on other countries," he said. (*)